Award
Delivery Order #SPE2DP26F2824
Delivery Order for Lisinopril Tablets Under Definitive Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$1.66
Ceiling
$1.66
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 13, 2026
Identifier
SPE2DP26F2824
NAICS
424210
This delivery order represents a specific contract action under a larger definitive pharmaceutical supply contract awarded to DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceuticals. The recipient will provide Lisinopril tablets, a medication used to treat high blood pressure and heart-related conditions, supporting federal health agency medication needs. This contract action is a component of a broader, multi-year agreement aimed at ensuring a reliable supply of essential drugs across various medical treatments. The scope involves the delivery of the specified pharmaceutical product at the specified place of performance in Park Ridge, Illinois. The award complements a long-term definitive contract awarded previously, which included diverse pharmaceutical products such as injectable solutions and oral tablets. This delivery order likely follows a competitive bidding process inherent to the indefinite delivery vehicle contract structure, contributing to a strategic and sustained healthcare procurement effort. The contract was awarded recently with a performance period on the order date, emphasizing timely fulfillment of medication supply requirements.
Description
8511920845!LISINOPRIL TABLETS,